Home » Topics » Regulatory » Patents

Patents
RSS

Leopold-Franzens Universitaet Innsbruck patents KOR agonists

Oct. 17, 2016

Anvyl presents deuterated etifoxine analogs

Oct. 14, 2016

Vertex Pharmaceuticals develops PAR2 antagonists

Oct. 14, 2016

McGill University and Florida Institute of Technology describe OXER1 antagonists

Oct. 14, 2016

Sichuan Kelun Pharmaceutical Research discloses anticancer agents

Oct. 14, 2016

Shenyang Sunshine Pharmaceutical patents PHD2 inhibitors

Oct. 14, 2016

Takeda Pharmaceutical presents EIT6 inhibitors

Oct. 13, 2016

BioNTech develops seprase binding peptides

Oct. 13, 2016

ChemBridge describes GPR131 agonists

Oct. 13, 2016

Abide Therapeutics discloses monoacylglycerol lipase inhibitors

Oct. 13, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 14, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026